샘플 요청 목록

 카트 문의
시장보고서
상품코드
1875982

세계의 단세포 분석 시장

Single-Cell Analysis
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 179 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 단세포 분석 시장은 2030년까지 280억 달러에 달할 전망

2024년에 101억 달러로 추정되는 세계의 단세포 분석 시장은 2024-2030년의 분석 기간에 CAGR 18.6%로 성장하며, 2030년까지 280억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석 대상 부문의 하나인 암 응용 분야는 20.5%의 CAGR을 기록하며, 분석 기간 종료까지 111억 달러에 달할 것으로 예측됩니다. 면역학 응용 분야의 성장률은 분석 기간에 19.4%의 CAGR로 추정되고 있습니다.

미국 시장은 27억 달러로 추정되는 한편, 중국은 17.1%의 CAGR로 성장할 것으로 예측됩니다.

미국의 단세포 분석 시장은 2024년에 27억 달러로 추정되고 있습니다. 세계 2위의 경제 규모를 자랑하는 중국은 2024-2030년의 분석 기간에 17.1%의 CAGR로 추이하며, 2030년까지 41억 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역 시장으로는 일본과 캐나다를 들 수 있으며, 각각 분석 기간 중 17.1%, 15.6%의 CAGR로 성장할 것으로 예측됩니다. 유럽에서는 독일이 약 13.0%의 CAGR로 성장할 것으로 전망되고 있습니다.

세계의 단세포 분석 시장 - 주요 동향과 촉진요인 요약

단일 세포 분석이 생의학 연구에 필수적인 이유는 무엇인가?

단일 세포 분석은 세포의 이질성에 대한 매우 상세한 정보를 제공하고, 연구자들이 복잡한 생물학적 시스템을 전례 없는 수준으로 이해할 수 있게 해주기 때문에 생의학 연구에 필수적인 요소로 자리 잡았습니다. 전체 세포 집단의 평균 데이터를 제공하는 벌크 세포 분석과 달리, 단일 세포 분석은 개별 세포를 조사하여 고유한 세포 상태와 기능을 밝힐 수 있습니다. 이 능력은 종양학, 면역학, 발생생물학 등의 분야에서 매우 중요합니다. 이러한 분야에서는 세포의 다양성과 거동을 이해하는 것이 질병 기전 규명, 바이오마커 발굴, 표적치료제 개발의 핵심입니다. 그 결과, 정밀의료를 촉진하고 환자의 치료 결과를 개선하기 위해 학술연구, 의약품 개발, 임상 진단에서 단일 세포 분석이 점점 더 많이 채택되고 있습니다.

기술 발전은 단일 세포 분석의 능력을 어떻게 향상시키고 있는가?

기술 발전은 데이터 수집 및 해석의 정확성, 처리 능력, 접근성을 향상시킴으로써 단일 세포 분석의 능력을 크게 향상시키고 있습니다. 고처리량 단일 세포 RNA 시퀀싱(scRNA-seq), 매스 사이토메트리, 마이크로플루이딕스 기술 기반의 플랫폼 개발로 수천 개의 개별 세포를 동시에 분석할 수 있게 되어 세포의 이질성에 대한 종합적인 지식을 얻을 수 있게 되었습니다. 또한 유전체학, 전사체학, 단백질체학, 대사체학 데이터를 통합하는 멀티오믹스 접근법의 혁신으로 단일 세포 분석의 범위가 RNA 발현에만 국한되지 않고 확대되고 있습니다. 데이터 분석 및 해석을 위한 인공지능(AI)과 머신러닝(ML)의 통합은 복잡한 데이터세트에서 의미 있는 인사이트를 추출하는 프로세스를 효율화합니다. 이러한 발전으로 단일 세포 분석은 더욱 강력하고 확장성이 뛰어나며 사용자 친화적이어서 다양한 연구 및 임상 현장에서의 채택을 촉진하고 있습니다.

단일 세포 분석의 도입을 주도하는 시장 부문은?

단일 세포 분석 기술의 유형에는 소모품(시약, 키트, 기기)과 장비(유세포분석기, 질량분석기, 시퀀싱 플랫폼)가 포함됩니다. 단일 세포 분석의 용도는 암 연구, 면역학, 신경학, 줄기세포 연구, 발생생물학에 이르기까지 다양하며, 종양 미세환경의 이해와 면역세포 프로파일링에 대한 높은 수요로 인해 암 연구와 면역학이 시장을 주도하고 있습니다. 최종사용자로는 학술연구기관, 제약 및 생명공학 기업, 병원 및 진단검사실 등이 있으며, 기초 및 중개연구에 중점을 둔 학술연구기관이 주요 개발 주체입니다. 지역별로는 북미와 유럽이 강력한 연구 자금, 첨단 의료 인프라, 다수의 바이오테크 스타트업 기업을 배경으로 단일 세포 분석의 가장 큰 시장을 형성하고 있습니다. 한편, 아시아태평양은 확대되는 생물의학 연구 활동과 증가하는 의료 투자에 힘입어 고성장 지역으로 부상하고 있습니다.

단일 세포 분석 시장의 성장을 이끄는 주요 요인은?

단일세포 분석 시장의 성장은 정밀의료 및 표적치료에 대한 수요 증가, 하이스루풋 및 멀티오믹스 단일세포 플랫폼의 기술 발전, 암 연구, 면역학, 신경학 분야에서의 단일세포 분석 활용 확대 등 여러 요인에 의해 촉진되고 있습니다. 사용자 친화적이고 자동화 및 확장 가능한 단일 세포 분석 시스템의 개발은 학술연구자, 제약 회사, 임상 실험실에서 시장 도입을 촉진하고 있습니다. 효율적인 데이터 분석, 해석, 시각화를 위한 AI와 머신러닝의 통합에 집중하면서 다양한 최종사용자층에서 시장 확대가 가속화되고 있습니다. 신약 개발, 바이오마커 개발, 개인 맞춤형 치료 전략에서 단일 세포 분석의 사용 확대와 혁신적이고 비용 효율적이며 정밀한 툴에 대한 수요가 결합하여 시장 성장의 새로운 기회를 창출하고 있습니다. 또한 비침습적, 무표지, 고해상도 단일 세포 분석 기법에 대한 R&D 투자 증가는 시장 확대를 더욱 촉진하고 있습니다.

부문 :

용도별(암, 면역학, 줄기세포, 비침습적 출생전진단, 신경학, 기타 용도) ; 용도별(학술·연구소, 바이오테크놀러지·제약 기업, 병원·진단 검사 기관 , 기타 용도)

조사 대상 기업의 예

  • Agilent Technologies, Inc.
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Fluidigm Corporation
  • GE Healthcare
  • Illumina, Inc.
  • Merck KgaA
  • Qiagen NV
  • Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

검증된 전문가 컨텐츠와 AI 툴을 통해 시장 및 경쟁 정보 분석을 혁신하고 있습니다.

Market Glass, Inc.는 LLM이나 산업 특화형 SLM을 쿼리하는 일반적인 방식이 아닌, 전 세계 도메인 전문가들이 엄선한 컨텐츠 리포지토리를 구축했습니다. 여기에는 비디오 전사, 블로그, 검색엔진 조사, 그리고 방대한 양의 기업, 제품/서비스, 시장 데이터가 포함됩니다.

관세 영향 계수

Market Glass, Inc.가 본사 소재지, 생산기지, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁 변화를 예측하면서 지역적 시장에 대한 관세의 영향을 반영했습니다. 이러한 복잡하고 다면적인 시장 현실은 수입원가(COGS) 증가, 수익성 하락, 공급망 재편 등 경쟁사에게 다양한 영향을 미치며, 미시적 및 거시적 시장 역학에도 영향을 미칩니다.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 세계의 기타 지역

제4장 경쟁

KSA 25.12.01

Global Single-Cell Analysis Market to Reach US$28.0 Billion by 2030

The global market for Single-Cell Analysis estimated at US$10.1 Billion in the year 2024, is expected to reach US$28.0 Billion by 2030, growing at a CAGR of 18.6% over the analysis period 2024-2030. Cancer Application, one of the segments analyzed in the report, is expected to record a 20.5% CAGR and reach US$11.1 Billion by the end of the analysis period. Growth in the Immunology Application segment is estimated at 19.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.7 Billion While China is Forecast to Grow at 17.1% CAGR

The Single-Cell Analysis market in the U.S. is estimated at US$2.7 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$4.1 Billion by the year 2030 trailing a CAGR of 17.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 17.1% and 15.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.0% CAGR.

Global Single-Cell Analysis Market - Key Trends and Drivers Summarized

Why Is Single-Cell Analysis Becoming Indispensable in Biomedical Research?

Single-cell analysis has become indispensable in biomedical research due to its ability to provide highly detailed insights into cellular heterogeneity, allowing researchers to understand complex biological systems at an unprecedented level. Unlike bulk cell analysis, which offers averaged data across a population of cells, single-cell analysis enables the examination of individual cells, revealing unique cellular states and functions. This capability is crucial for fields such as oncology, immunology, and developmental biology, where understanding cellular diversity and behavior is key to identifying disease mechanisms, discovering biomarkers, and developing targeted therapies. As a result, single-cell analysis is increasingly being adopted in academic research, pharmaceutical development, and clinical diagnostics to advance precision medicine and improve patient outcomes.

How Are Technological Advancements Enhancing the Capabilities of Single-Cell Analysis?

Technological advancements are significantly enhancing the capabilities of single-cell analysis by improving the accuracy, throughput, and accessibility of data collection and interpretation. The development of high-throughput single-cell RNA sequencing (scRNA-seq), mass cytometry, and microfluidics-based platforms has enabled the simultaneous analysis of thousands of individual cells, providing a comprehensive view of cellular heterogeneity. Moreover, innovations in multi-omics approaches, which integrate genomics, transcriptomics, proteomics, and metabolomics data, are expanding the scope of single-cell analysis beyond just RNA expression. The integration of artificial intelligence (AI) and machine learning (ML) for data analysis and interpretation is also streamlining the extraction of meaningful insights from complex datasets. These advancements are making single-cell analysis more robust, scalable, and user-friendly, thereby driving its adoption across various research and clinical settings.

Which Market Segments Are Leading the Adoption of Single-Cell Analysis?

Types of single-cell analysis technologies include consumables (reagents, kits, and instruments) and instruments (flow cytometers, mass spectrometers, and sequencing platforms). Applications of single-cell analysis span cancer research, immunology, neurology, stem cell research, and developmental biology, with cancer research and immunology leading the market due to the high demand for understanding tumor microenvironments and immune cell profiling. End-users include academic and research institutions, pharmaceutical and biotechnology companies, and hospitals and diagnostic laboratories, with academic and research institutions being the primary adopters due to their focus on basic research and translational studies. Geographically, North America and Europe are the largest markets for single-cell analysis due to strong research funding, advanced healthcare infrastructure, and a high number of biotech startups, while Asia-Pacific is emerging as a high-growth region driven by expanding biomedical research activities and increasing healthcare investments.

What Are the Key Drivers of Growth in the Single-Cell Analysis Market?

The growth in the single-cell analysis market is driven by several factors, including the rising demand for precision medicine and targeted therapies, technological advancements in high-throughput and multi-omics single-cell platforms, and the increasing use of single-cell analysis in cancer research, immunology, and neurology. The development of user-friendly, automated, and scalable single-cell analysis systems is driving market adoption among academic researchers, pharmaceutical companies, and clinical laboratories. The focus on integrating AI and machine learning for efficient data analysis, interpretation, and visualization is expanding the market reach among diverse end-users. The growing use of single-cell analysis in drug discovery, biomarker development, and personalized treatment strategies, coupled with the demand for innovative, cost-effective, and high-precision tools, is creating new opportunities for market growth. Additionally, the increasing investments in R&D for non-invasive, label-free, and high-resolution single-cell analysis methods are further supporting market expansion.

SCOPE OF STUDY:

The report analyzes the Single-Cell Analysis market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology, Other Applications); End-Use (Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 11 Featured) -

  • Agilent Technologies, Inc.
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Fluidigm Corporation
  • GE Healthcare
  • Illumina, Inc.
  • Merck KgaA
  • Qiagen NV
  • Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
    • Global Economic Update
    • Single-Cell Analysis - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Precision Medicine and Targeted Therapies Spurs Single-Cell Analysis Market Growth
    • Technological Advancements in Genomics, Transcriptomics, and Proteomics Strengthen the Business Case for Single-Cell Analysis
    • Increasing Adoption of Single-Cell Analysis in Cancer Research Expands Addressable Market Opportunity
    • Development of High-Throughput and High-Resolution Single-Cell Analysis Platforms Drives Adoption
    • Growing Focus on Understanding Cellular Heterogeneity and Immune System Dynamics Generates New Market Opportunities
    • Integration of Artificial Intelligence and Machine Learning in Data Analysis Throws Spotlight on Single-Cell Analysis Market Potential
    • Expansion of Single-Cell Analysis Applications in Neurology, Immunology, and Developmental Biology Creates New Growth Avenues
    • Development of User-Friendly, Automated, and Multi-Omics Single-Cell Platforms Reinforces Market Adoption
    • Growing Demand for Single-Cell Sequencing in Drug Discovery and Development Sustains Market Growth
    • Focus on Developing Non-Invasive, Label-Free, and High-Precision Single-Cell Analysis Methods Drives Innovation
    • Rising Adoption of Single-Cell Analysis in Clinical Diagnostics and Biomarker Discovery Spurs Market Demand
    • Shift Towards Single-Cell Multi-Omics and Spatial Transcriptomics Strengthens Market Competitiveness
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Single-Cell Analysis Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Single-Cell Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Single-Cell Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Single-Cell Analysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Immunology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Immunology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Immunology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Stem Cell by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Stem Cell by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Stem Cell by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Non-Invasive Prenatal Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Non-Invasive Prenatal Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Non-Invasive Prenatal Diagnosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Academic & Research Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Academic & Research Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Academic & Research Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Biotech & Pharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Biotech & Pharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Biotech & Pharma Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Hospitals & Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Hospitals & Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Hospitals & Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Single-Cell Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Single-Cell Analysis by Application - Percentage Breakdown of Value Sales for Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Single-Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Single-Cell Analysis by Application - Percentage Breakdown of Value Sales for Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Single-Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Single-Cell Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Single-Cell Analysis by Application - Percentage Breakdown of Value Sales for Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Single-Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Single-Cell Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 53: China Recent Past, Current & Future Analysis for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: China 15-Year Perspective for Single-Cell Analysis by Application - Percentage Breakdown of Value Sales for Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: China 15-Year Perspective for Single-Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Single-Cell Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Single-Cell Analysis by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Single-Cell Analysis by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Single-Cell Analysis by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for Single-Cell Analysis by Application - Percentage Breakdown of Value Sales for Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Single-Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Single-Cell Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 68: France Recent Past, Current & Future Analysis for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: France 15-Year Perspective for Single-Cell Analysis by Application - Percentage Breakdown of Value Sales for Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 71: France Recent Past, Current & Future Analysis for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: France 15-Year Perspective for Single-Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Single-Cell Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Germany 15-Year Perspective for Single-Cell Analysis by Application - Percentage Breakdown of Value Sales for Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Germany 15-Year Perspective for Single-Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Italy 15-Year Perspective for Single-Cell Analysis by Application - Percentage Breakdown of Value Sales for Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Italy 15-Year Perspective for Single-Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Single-Cell Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 86: UK Recent Past, Current & Future Analysis for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: UK 15-Year Perspective for Single-Cell Analysis by Application - Percentage Breakdown of Value Sales for Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 89: UK Recent Past, Current & Future Analysis for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: UK 15-Year Perspective for Single-Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Single-Cell Analysis by Application - Percentage Breakdown of Value Sales for Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Single-Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Single-Cell Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Single-Cell Analysis by Application - Percentage Breakdown of Value Sales for Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Single-Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 104: Rest of World Recent Past, Current & Future Analysis for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of World Historic Review for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Rest of World 15-Year Perspective for Single-Cell Analysis by Application - Percentage Breakdown of Value Sales for Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 107: Rest of World Recent Past, Current & Future Analysis for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of World Historic Review for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Rest of World 15-Year Perspective for Single-Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제